Vimarsana
Biggest News Aggregation in the World

Page 2 - Clinical Features News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Features. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Features Today - Breaking & Trending Today

Low FODMAP Diet: What It Is, Benefits & Sample Meal Plans 2024 - Vimarsana News

Low FODMAP Diet: What It Is, Benefits & Sample Meal Plans 2024

Do you have digestive problems like gas, diarrhea, or constipation? A proper diet can help you. Let's examine the low-FODMAP diet 2024 .

Understanding Myelofibrosis: Disease Spectrum and Impact on Quality of Life - Vimarsana News

Understanding Myelofibrosis: Disease Spectrum and Impact on Quality of Life

Aaron Gerds, MD, MS, compares myelofibrosis with other myeloproliferative neoplasms, explores its prevalence in the US, and reviews the diverse clinical presentations and the impact on patients’ quality of life.

Source: ajmc.com
GSK : New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence -November 30, 2023 at 04:14 am EST - Vimarsana News

GSK : New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence -November 30, 2023 at 04:14 am EST

A new GSK survey shows a large number of adults do not understand how shingles may be triggered1 More than half of adults surveyed incorrectly believe that you...

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata - Vimarsana News

Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata

-- Alopecia areata is the second autoimmune indication being evaluated for bempikibart -- ...

GSK positive results from first-ever efficacy trial of Shingrix in China - Vimarsana News

GSK positive results from first-ever efficacy trial of Shingrix in China

GSK positive results from first-ever efficacy trial of Shingrix in China